SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Suntzu who wrote (29914)12/17/1998 11:36:00 AM
From: Gravitar  Respond to of 119973
 
Repligen Announces Agreement with Amersham Pharmacia Biotech Repligen to Supply Recombinant Protein A to APBiotech


December 17, 1998 11:30 AM
NEEDHAM, Mass., Dec. 17 /PRNewswire/ -- Repligen Corporation RGEN announced today an agreement with Amersham Pharmacia Biotech ("APBiotech") on the manufacture of APBiotech's recombinant Protein A. Protein A is a naturally occurring protein which has the ability to bind antibodies with high specificity. Devices containing Protein A attached (immobilized) to a solid support are used by biotechnology and pharmaceutical companies to manufacture therapeutic monoclonal antibodies and related proteins.
The



To: Suntzu who wrote (29914)12/17/1998 11:37:00 AM
From: kendall harmon  Read Replies (2) | Respond to of 119973
 
CCL is the stock I commend to people's attention today. It has been steadily moving higher all morning making higher highs. The earnings news was excellent--first call estimate was 33 and the company made 37. The chart is also terrific.

These are some of the best plays in this environment--good companies in good niches with positive earnings surprises that make higher highs.

This is exactly the kind of action ZQK had yesterday.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News